Key Insights DexCom's estimated fair value is US$116 based on 2 Stage Free Cash Flow to Equity DexCom is estimated ...

The stock's fall snapped a two-day winning streak.

DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 15.6% to $87 per share. This was ...

DexCom, Inc. (DXCM), with a market cap of $33.9 billion, is a leading medical device company specializing in continuous ...

Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 12.5% year on ...

25 analysts are following DexCom and have set target prices ranging from $82.0 to $110.0 per share. On average, they have ...

DexCom Inc. closed 34.58% short of its 52-week high of $132.26, which the company reached on May 17th.

Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment industry.

Dexcom (Nasdaq: DXCM) today announced a significant internal promotion for a longtime member of its leadership team.

SAN DIEGO, May 01, 2025--Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program SAN DIEGO, April 22, 2025--DexCom, Inc. (NASDAQ: DXCM), the global ...

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other best medical device ...

Dexcom (NASDAQ:DXCM) announced today that it expanded its partnership with Oura, officially launching an integration with ...